» Articles » PMID: 27037767

Atheroprotective Effects of Conjugated Linoleic Acid

Overview
Specialty Pharmacology
Date 2016 Apr 3
PMID 27037767
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis, the underlying cause of heart attack and strokes, is a progressive dyslipidaemic and inflammatory disease where monocyte-derived macrophage cells play a pivotal role. Although most of the mechanisms that contribute to the progression of atherosclerosis have been identified, there is limited information on those governing regression. Conjugated linoleic acid (CLA) is a generic term denoting a group of naturally occurring isomers of linoleic acid (18:2, n6) that differ in the position or geometry (i.e. cis or trans) of their double bonds. The most predominant isomers in ruminant fats are cis-9, trans-11 CLA (c9,t11-CLA), which accounts for more than 80% of CLA isomers in dairy products and trans-10, cis-12 CLA (t10,c12-CLA). Dietary administration of a blend of the two most abundant isomers of CLA has been shown to inhibit the progression and induce the regression of pre-established atherosclerosis. Studies investigating the mechanisms involved in CLA-induced atheroprotective effects are continually emerging. The purpose of this review is to discuss comprehensively the effects of CLA on monocyte/macrophage function in atherosclerosis and to identify possible mechanisms through which CLA mediates its atheroprotective effects.

Citing Articles

A global analysis of dairy consumption and incident cardiovascular disease.

Zhuang P, Liu X, Li Y, Ao Y, Wu Y, Ye H Nat Commun. 2025; 16(1):437.

PMID: 39762253 PMC: 11704150. DOI: 10.1038/s41467-024-55585-0.


A dietary intervention with conjugated linoleic acid enhances microstructural white matter reorganization in experimental stroke.

Straeten F, Strecker J, Borsch A, Maus B, Hoppen M, Schmeddes B Front Neurol. 2024; 15:1341958.

PMID: 39372701 PMC: 11449868. DOI: 10.3389/fneur.2024.1341958.


Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment.

Wang H, Yung M, Xuan Y, Chen F, Chan W, Siu M Exp Hematol Oncol. 2024; 13(1):90.

PMID: 39198883 PMC: 11360340. DOI: 10.1186/s40164-024-00558-8.


Healthy Effects of Milk and Dairy Product Consumption in the Mediterranean Area and Japan.

Jirillo F Endocr Metab Immune Disord Drug Targets. 2024; 24(15):1813-1822.

PMID: 38994611 DOI: 10.2174/0118715303289711240703080701.


Conjugated Linoleic Acid Ameliorates High Fat-Induced Insulin Resistance via Regulating Gut Microbiota-Host Metabolic and Immunomodulatory Interactions.

Wu L, Ye S, Deng X, Fu Z, Li J, Yang C Nutrients. 2024; 16(8).

PMID: 38674824 PMC: 11053735. DOI: 10.3390/nu16081133.


References
1.
Galkina E, Ley K . Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol. 2009; 27:165-97. PMC: 2734407. DOI: 10.1146/annurev.immunol.021908.132620. View

2.
Gerszten R, Mach F, Sauty A, Rosenzweig A, Luster A . Chemokines, leukocytes, and atherosclerosis. J Lab Clin Med. 2000; 136(2):87-92. DOI: 10.1067/mlc.2000.108154. View

3.
Moya-Camarena S, Vanden Heuvel J, Blanchard S, Leesnitzer L, Belury M . Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J Lipid Res. 1999; 40(8):1426-33. View

4.
Arbones-Mainar J, Navarro M, Guzman M, Arnal C, Surra J, Acin S . Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice. Atherosclerosis. 2006; 189(2):318-27. DOI: 10.1016/j.atherosclerosis.2006.01.015. View

5.
Al-Mamari A . Atherosclerosis and physical activity. Oman Med J. 2012; 24(3):173-8. PMC: 3251175. DOI: 10.5001/omj.2009.34. View